This blue-chip guide adds quality to the pharmaceutical clinical development process by detailing the need for, and stressing the importance of, an independent audit of clinical data to protect participants and validate study results.
Examines the use of personal computers, the Internet, and third-party organizations to assist in data validation!
Positioning the audit as the only reliable tool to verify that a drug has been shown to be safe and effective in clinical trials, The Clinical Audit in Pharmaceutical Development

recommends establishing auditing and quality assurance at the beginning of a clinical study

describes Good Clinical Practices (GCPs) and the role of regulatory agencies in the review, validation, and auditing processes

outlines the clinical process, from trial design through report writing

compares and contrasts United States and international regulatory statutes

identifies monitoring as the key to guaranteeing high-quality data

focuses on the role of the clinical audit in achieving unity in a multinational study

discusses the worldwide influence of the US Food and Drug Administration audit

analyzes findings from previous FDA clinical audits to reveal trends and future directions

provides guidelines for fraud detection and considers the ramifications of falsified data

and more!
Confirming that all clinical information has been properly collected and reported, The Clinical Audit in Pharmaceutical Development is a crucial reference for clinical and research pharmacists and pharmacologists; biostatisticians; clinical research associates, coordinators, and investigators; quality control, quality assurance, and regulatory compliance managers; and upper-level undergraduate and graduate students in these disciplines.

� propos de l?auteur

Michael R. Hamrell

Les informations fournies dans la section � A propos du livre � peuvent faire r�f�rence � une autre �dition de ce titre.

Description de la librairie

Visitez la page d�accueil du vendeur

Informations commerciales relatives au vendeur

Edward Bowditch Ltd
Exstowe, Exton, Exeter, EX3 0PP, United Kingdom

Conditions de vente et de livraison

Conditions g�n�rales de vente

Legal entity name: Edward Bowditch Ltd
Legal entity form: Limited company
Business correspondence address: Exstowe, Exton, Exeter, EX3 0PP
Company registration number: 04916632
VAT registration: GB834241546
Authorised representative: Mr. E. Bowditch

Droit de r�tractation

Conditions d'exp�dition

Orders usually dispatched within two working days.

Frais d?exp�dition de Royaume-Uni�vers�Etats-Unis

Frais d?exp�dition de Royaume-Uni�vers�Etats-Unis
Quantit� command�e	7 � 18 jours ouvr�s	2 � 5 jours ouvr�s
Premier article	EUR 28.77	EUR 28.77

Les d�lais de livraison sont fix�s par les vendeurs et varient en fonction du transporteur et du lieu. Les commandes transitant par les douanes peuvent �tre retard�es et les acheteurs sont responsables de tous les droits ou frais associ�s. Les vendeurs peuvent vous contacter au sujet de frais suppl�mentaires afin de couvrir toute augmentation des co�ts d'exp�dition de vos articles.